References
- Ko MA, Zehong G, Virtanen C et al. miRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy. Ann. Thorac. Surg. 94(4), 1094–1103 (2012).
- Schetter AJ, Leung SY, Sohn JJ et al. miRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299(4), 425–436 (2008).
- Hummel R, Watson DI, Smith C et al. Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. J. Gastrointest. Surg. 15(3), 429–438 (2011).
- Bourgon R, Gentleman R, Huber W. Independent filtering increases detection power for high-throughput experiments. Proc. Natl Acad. Sci. USA 107(21), 9546–9551 (2010).
- Bhatia S, Frangioni JV, Hoffman RM, Iafrate AJ, Polyak K. The challenges posed by cancer heterogeneity. Nat. Biotechnol. 30(7), 604–610 (2012).
- Hu Y, Correa AM, Hoque A et al. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int. J. Cancer 128(1), 132–143 (2011).
- Hummel R, Hussey DJ, Michael MZ et al. MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. Ann. Surg. Oncol. 18(1), 253–260 (2011).
- Cordes KR, Sheehy NT, White MP et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460(7256), 705–710 (2009).
- López-Lago MA, Thodima VJ, Guttapalli A et al. Genomic deregulation during metastasis of renal cell carcinoma implements a myofibroblast-like program of gene expression. Cancer Res. 70(23), 9682–9692 (2010).
- Owonikoko T, Rees M, Gabbert HE, Sarbia M. Intratumoral genetic heterogeneity in Barrett adenocarcinoma. Am. J. Clin. Pathol. 117(4), 558–566 (2002).
- Merlo LM, Shah NA, Li X et al. A comprehensive survey of clonal diversity measures in Barrett’s esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev. Res. (Phila.) 3(11), 1388–1397 (2010).
- Kihara C, Tsunoda T, Tanaka T et al. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res. 61(17), 6474–6479 (2001).